SEC 13F Intelligence

ACCELERATE DIAGNOSTICS INC

CUSIP 00430H102

Accelerate Diagnostics Inc has 64 institutional holders in Filings Flow’s 13F database, together reporting 20.76M shares worth $12M as of Q4 2022.

Institutional Holders
64
Q4 2022
Reported Value
$12M
Ticker
unmapped
private placement or foreign
Quarters Tracked
7

Ownership Trend

Institutional holders
Q4 ’18: 86Q4 ’18Q1 ’19: 92Q1 ’19Q2 ’19: 98Q2 ’19Q3 ’19: 93Q3 ’19Q2 ’21: 83Q2 ’21Q4 ’21: 94Q4 ’21Q4 ’22: 64Q4 ’22filingsflow.com
Total reported value
Q4 ’18: $436MQ4 ’18Q1 ’19: $918MQ1 ’19Q2 ’19: $973MQ2 ’19Q3 ’19: $2.3BQ3 ’19Q2 ’21: $428MQ2 ’21Q4 ’21: $306MQ4 ’21Q4 ’22: $12MQ4 ’22filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
Birchview Capital, LP$176M AUM0.00%$2,082325.2KQ2 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.